UCB to divest mature neurology and allergy portfolio in China for $680m to CBC Group and Mubadala
UCB, a Belgian biopharmaceutical company, has announced the divestment of its mature neurology and allergy portfolio in China for $680 million, marking a strategic shift ... Read More
Novocuff secures $26m in Series A funding to combat preterm births
Novocuff, Inc., has successfully closed an oversubscribed $26 million Series A funding round to advance their mission of improving pregnancy outcomes and reducing the incidence ... Read More
Earned Wealth announces $200m capital injection for expansion and acquires Thomas Doll
In a significant move to bolster its unique financial services tailored for medical professionals, Earned Wealth, a leading tech-enabled financial services firm, has successfully secured ... Read More
Triton Pacific Healthcare Partners sells BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners
Triton Pacific Healthcare Partners, a notable healthcare-focused private equity group, has successfully concluded the sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. While ... Read More
Cipla boosts investment in Ethris to advance mRNA therapies in emerging markets
Cipla Limited has announced an additional investment of EUR 3 million in Ethris GmbH, further strengthening its involvement in the mRNA technology sector. This move ... Read More
Fischer Medical Ventures partners with Wonder Tech to transform mental healthcare
Fischer Medical Ventures Ltd, formerly known as Fischer Chemic Limited, has formalized its investment in the Singapore-based Wonder Tech Group, marking a significant step in ... Read More
Shore Capital Partners sells Behavioral Innovations to Tenex Capital Management amid significant expansion
Shore Capital Partners, a private equity firm based in Chicago known for its focus on microcap investments, has successfully completed the sale of Behavioral Innovations ... Read More
Johnson & Johnson strikes $1.2bn deal with Numab Therapeutics for atopic dermatitis candidate
In a significant move to enhance its immunology offerings, Johnson & Johnson (NYSE: JNJ) has announced a definitive agreement to acquire a wholly-owned subsidiary of ... Read More
KKR to acquire controlling interest in Healthium Medtech from Apax Partners
In a significant development within the medical technology sector, KKR, a prominent global investment firm, has agreed to purchase a controlling stake in Healthium Medtech ... Read More
AstraZeneca posts strong Q1 2024 results with significant revenue and EPS growth
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679 million, marking a 19% increase at constant ... Read More